Furthermore, higher GCN5 expression within cancer samples was evidently associated with poor overall survival (OS) in KIRC, SARC, ACC, and LAML malignancies, as demonstrated by Kaplan–Meier analysis (Fig. 7h). Here, KAT2B is linked to cancer.